Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Clinical trial protocol1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

Stephanie L. Wethington,Payal D. Shah,Lainie Martin,Janos L. Tanyi,Nawar Latif,Mark Morgan,Drew A. Torigian,Diego Rodriguez,Simon A. Smith,Emma Dean,Susan M. Domchek,Ronny Drapkin,Ie-Ming Shih,Eric J. Brown,Wei-Ting Hwang,Deborah K. Armstrong,Stephanie Gaillard,Robert Giuntoli,Fiona Simpkins

crossref（2023）

Cited 0|Views2
No score
Abstract
Trial protocol
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined